SHILPAMEDNSEShilpa Medicare Limited· PharmaceuticalsHighNeutral
Announced Mon, 27 Oct · 17:02 IST

Shilpa Medicare Limited has informed the Exchange about that Shilpa Medicare Limited have signed definitive agreement to sell 31% stake in Sravathi Advance Process Technologies Pvt Ltd.

Core Business DivestedStrategic Transactions View source PDF

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shilpa Medicare Limited has signed a definitive agreement to sell its 31% stake in Sravathi Advance Process Technologies Pvt Ltd. The company has informed the stock exchange about this stake sale transaction. The buyer and deal value have not been disclosed in this filing. Sravathi Advance Process Technologies is a private subsidiary/associate of Shilpa Medicare in the process technologies space.

Likely market impact

This divestiture will reduce Shilpa Medicare's exposure in the process technologies segment and could free up capital for the company's core pharma operations. Shareholders should watch for further disclosures on the deal valuation and the buyer's identity, as the stock may react to the sale price and strategic direction implications.